The Global Pharmaceutical Fine Chemicals Market Outlook to 2015
Scripp Business Insights, January 2011, Pages: 94
This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market. The report also analyzes the global PFC industry in terms of market dynamics (market size, drivers and resistors of growth), key merger and acquisitions and recent trends in the industry.
Features and benefits
- Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure.
- Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market.
- Understand the basic PFC manufacturing processes and the raw materials used in their production.
- Understand how recent trends in the pharmaceutical market are responsible for shaping the trends in the PFC industry.
- Analyze the performance of the leading PFC players and gain an insight into their geographic reach, business segments, revenues, growth strategies.
Highlights
Pharmaceutical fine chemicals are chemicals used in the manufacture of pharmaceutical products. The pharmaceutical industry being one of the largest clients of PFC industry, not only affects the sales dynamics of the PFC industry, but also catalyses certain trends in this industry.
The relative importance of India and China as manufacturing areas for fine chemicals and pharmaceutical APIs has increased over recent decades because of the cost benefits that these countries offer to the pharmaceutical companies.
The drive towards cost reduction in the pharmaceutical industry will continue to create pricing pressure on the fine chemicals industry. Moreover, the consolidation of the pharmaceutical sector will also reduce the number of potential customers for the PFC industry.
Your key questions answered
- What is the market size and growth rate of the global pharmaceutical fine chemicals market?
- What are the main trends driving the growth of the global PFC market and how is the ‘patent cliff’ impacting PFC sales?
- Which are the key deals and alliances in the global PFC industry and how will they impact the stakeholders?
- Which are the leading players in the global PFC market and what are their growth strategies?
- What are the key technological developments in the global PFC market?"
About Business Insights
Disclaimer
Executive summary
Industry overview
Market overview
Recent trends in the pharmaceutical fine chemicals industry
Competitive landscape
Scope and methodology
Scope
Methodology
Chapter 1 Industry overview
Summary
Introduction
Classification of pharmaceutical fine chemicals (PFCs)
Basic intermediates
Key intermediates
Active pharmaceutical ingredients
Demand for pharmaceutical fine chemicals
Supply of pharmaceutical fine chemicals
Production of pharmaceutical fine chemicals
Raw materials used for the production of PFCs
Manufacturing procedures
Current regulatory environment for pharmaceutical intermediates
GMP requirements
ICH Q7A
US GMP – Federal Food Drug and Cosmetic Act
EU GMP
China GMP – GMP for pharmaceutical products
India GMP – Drugs and cosmetics rules Schedule M
Drug Price Competition and Patent Term Restoration Act (‘Hatch-Waxman Act’)
REACH
Key deals and alliances in the global pharmaceutical fine chemicals market
Chapter 2 Market overview
Summary
Introduction
Market dynamics
Global market size and structure
Regional distribution
Future outlook of the global PFC market
Drivers and resistors of PFC industry
Drivers of the PFC industry
Resistors of the PFC industry
Chapter 3 Recent trends in the pharmaceutical fine chemicals industry
Summary
Introduction
Increasing pricing pressure on PFC companies
Downturn in the innovative API market; upturn in the generic API market
Increasing PFC outsourcing is creating new growth opportunities
Recent innovations in the PFC manufacturing processes
Small molecule production technologies
Biotechnological manufacturing methods
HPAPIs
Antibody-drug conjugates
Relocation to emerging and fast growing markets
Chapter 4 Competitive landscape
Summary
Introduction
Competitive landscape
Capability analysis
Albemarle Corporation
Company overview
Business segmentation
Financial performance
Growth strategy
BASF
Company overview
Business segmentation
Financial performance
Growth strategy
Boehringer Ingelheim
Company overview
Business segmentation
Financial performance
Growth strategy
Cambrex
Company overview
Business segmentation
Financial performance
Growth strategy
DSM
Company overview
Business segmentation
Financial performance
Growth strategy
Evonik
Company overview
Business segmentation
Financial performance
Growth strategy
Lonza
Company overview
Business segmentation
Financial performance
Growth strategy
Novasep
Company overview
Business segmentation
Financial performance
Growth strategy
Sigma-Aldrich
Company overview
Business segmentation
Financial performance
Growth strategy
Sumitomo Chemical
Company overview
Business segmentation
Financial performance
Growth strategy
Other major PFC companies
Archimica
Daiichi Fine Chemical
KemFine
Saltigo
Siegfried
Abbreviations
Table of figures
Figure 2: Classification of chemicals based on functionality and industrial applications
Figure 3: Supply chain of pharmaceutical fine chemicals
Figure 3: Relationship between the industries involved in the PFC market
Figure 4: Supply areas of pharmaceutical intermediates in 2009
Figure 5: Supply areas of Pharmaceutical intermediates in 2015
Figure 6: Drivers and resistors of pharmaceutical fine chemical industry
Figure 7: Pharmaceutical industry trends influencing the PFC industry
Figure 8: Effect of patent cliff on the API market
Figure 9: Capability analysis of the leading 10 PFC companies
Figure 10: Albemarle’s fine chemicals division net sales
Figure 11: Cambrex’s fine chemicals sales ($m), 2010
Figure 12: DSM’s pharmaceutical division net sales ($m), 2010
Figure 13: Evonik’s chemical division net sales ($m), 2010
Table of tables
Table 1: Differentiating characteristics of commodities, fine chemicals and specialty chemicals
Table 2: List of important basic pharmaceutical intermediates and their applications
Table 3: List of major natural sources used in the synthesis of APIs
Table 4: List of major petrochemical products used in the synthesis of APIs
Table 5: Global pharmaceutical market by country ($m), 2009
Table 6: Forecast sales performance of pharmaceutical fine chemicals, 2010–2015
Table 7: Patent expiries of key pharmaceutical compounds during 2010–2015
Table 8: Performance of leading PFC companies ($m), 2009
Table 9: BASF financial performance by segment ($m), 2009
Table 10: Boehringer Ingelheim financial performance by segment ($m), 2009
Table 11: DSM financial performance by segment ($m), 2009
Table 12: Evonik’s Chemical division sales ($m), 2009
Table 13: Lonza financial performance ($m), 2009
- Albemarle Corporation
- BASF
- Boehringer Ingelheim
- Cambrex
- DSM
- Evonik
- Lonza
- Novasep
- Sigma-Aldrich
- Sumitomo Chemical
- Archimica
- Daiichi Fine Chemical
- KemFine
- Saltigo
- Siegfried
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
